A new chip-and-robotics venture sounded like the kind of strategic move that could reignite investor enthusiasm for Ubtech Robotics. Instead, the market punished the stock. The Shenzhen-based humanoid specialist saw its shares fall 6.8% on Wednesday, closing at 109.80 Hong Kong dollars on turnover of 1.46 billion HKD — a far steeper decline than the Hang Seng Index’s 1.27% drop that day.
The catalyst was the formation of Xixuan Chuangzhi Technology in Wuxi, a joint venture involving Ubtech, the Shanghai-based AI chip developer MetaX, and a firm called Fenglong. The new entity is registered with 100 million renminbi in capital and aims to design and sell chips, develop robots, and build artificial-intelligence algorithms and software. On paper, it ties Ubtech directly into China’s push for home-grown AI hardware infrastructure — a strategic prize.
But the market sent a clear signal: a registration is not a revenue stream. The announcement contained no details on equity stakes, capital commitments, product roadmaps, or commercial contracts. And for a company that booked a net loss of 703 million renminbi in fiscal 2025 — or 1.55 renminbi per share — every new initiative is now judged on its ability to generate cash, not just headlines.
The scepticism comes at a moment when the broader narrative around Chinese humanoid robotics has never been more bullish. Since the commercial launch of humanoid robots in 2025, Chinese manufacturers have accounted for 81% of global deliveries. Just a year earlier, that figure stood at 54% of total robotic installations. The shift is powered by aggressive cost-cutting: LinkerBot, for instance, now produces dexterous robot hands for just 600 dollars, lowering the barrier to mass adoption in factories and service industries.
International capital has taken note. The Global X Robotics & Artificial Intelligence ETF (BOTZ), which holds Ubtech and manages roughly $3.5 billion, has gained 13% since the start of the year. More targeted humanoid funds have done even better: the BOTT ETF is up 35% in 2026, while the broader ROBO ETF has climbed 30%. Nvidia chief Jensen Huang recently estimated the addressable market for humanoid robots at $40 trillion, a figure that has captured institutional attention.
Should investors sell immediately? Or is it worth buying Ubtech Robotics?
Ubtech is also a direct beneficiary of Beijing’s digital plan to achieve technological dominance by 2035. Under that strategy, annual research budgets are slated to reach 580 billion dollars by the mid-2020s, with goals of 70% semiconductor self-sufficiency and the training of over 500,000 AI specialists. Analysts speak of a coming “robot-majority society”, with some forecasts predicting the global robot population will exceed the human one by 2040.
Yet the stock tells a different story. Ubtech’s shares closed at 12.08 euros in European trading, 29% below their 52-week high of 16.95 euros, and have lost nearly 17% since January. Measured in Hong Kong dollars, the year-to-date decline is roughly 17.5%, with the price still trading about 30% off its peak. The stock’s volatility stands at 58%.
Investors are now waiting for concrete details on the Wuxi venture: ownership structure, governance, funding plans, and first commercial projects. MetaX, the chip partner, has a track record in designing GPUs for AI inference and general computing, and noted in its 2025 annual report that demand from large language models and generative AI is a key growth driver. But without specifics, the partnership remains a strategic promise — and the market has made plain that promises alone no longer move the needle.
Geopolitical tensions and sector-wide swings remain headwinds. Yet the concentration of manufacturing and the sheer volume of domestic installations ensure Chinese robotics companies will stay central to global supply chains. Ubtech, for its part, remains the primary beneficiary of that industrial shift — provided it can translate promises into profits.
Ad
Ubtech Robotics Stock: Buy or Sell?! New Ubtech Robotics Analysis from May 29 delivers the answer:
The latest Ubtech Robotics figures speak for themselves: Urgent action needed for Ubtech Robotics investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 29.
Ubtech Robotics: Buy or sell? Read more here...
